These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 29399800)

  • 1. Double-blind, placebo-controlled study with alginate suspension for laryngopharyngeal reflux disease.
    Tseng WH; Tseng PH; Wu JF; Hsu YC; Lee TY; Ni YH; Wang HP; Hsiao TY; Hsu WC
    Laryngoscope; 2018 Oct; 128(10):2252-2260. PubMed ID: 29399800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LPR: how different diagnostic tools shape the outcomes of treatment.
    Wan Y; Yan Y; Ma F; Wang L; Lu P; Maytag A; Jiang JJ
    J Voice; 2014 May; 28(3):362-8. PubMed ID: 24491501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation analysis between Dx-pH monitoring and proton pump inhibitor test in the diagnosis of laryngopharyngeal reflux disease].
    Chen ZL; Wu HW; Mei XW; Yin WH; Xu SY; Liu SQ; Chen YC; Wang G; Zhang CJ; Ding XL; Wu JN
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Jan; 55(1):34-39. PubMed ID: 31954386
    [No Abstract]   [Full Text] [Related]  

  • 4. Randomised clinical trial: the clinical efficacy and safety of an alginate-antacid (Gaviscon Double Action) versus placebo, for decreasing upper gastrointestinal symptoms in symptomatic gastroesophageal reflux disease (GERD) in China.
    Sun J; Yang C; Zhao H; Zheng P; Wilkinson J; Ng B; Yuan Y
    Aliment Pharmacol Ther; 2015 Oct; 42(7):845-54. PubMed ID: 26228097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laryngopharyngeal Reflux Disease is More Severe in Obese Patients: A Prospective Multicenter Study.
    Lechien JR; Bobin F; Muls V; Saussez S; Hans S
    Laryngoscope; 2021 Nov; 131(11):E2742-E2748. PubMed ID: 34086292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual pH with Multichannel Intraluminal Impedance Testing in the Evaluation of Subjective Laryngopharyngeal Reflux Symptoms.
    Cumpston EC; Blumin JH; Bock JM
    Otolaryngol Head Neck Surg; 2016 Dec; 155(6):1014-1020. PubMed ID: 27554506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study with pharyngeal and esophageal 24-hour pH-impedance monitoring in patients with laryngopharyngeal symptoms refractory to proton pump inhibitors.
    Dulery C; Lechot A; Roman S; Bastier PL; Stoll D; de Gabory L; Zerbib F
    Neurogastroenterol Motil; 2017 Jan; 29(1):. PubMed ID: 27424517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimum Effective Duration of Laryngopharyngeal Reflux Disease Treatment: A Prospective Study.
    Lechien JR
    Otolaryngol Head Neck Surg; 2024 Oct; 171(4):1114-1122. PubMed ID: 38961817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rethinking the laryngopharyngeal reflux treatment algorithm: Evaluating an alternate empiric dosing regimen and considering up-front, pH-impedance, and manometry testing to minimize cost in treating suspect laryngopharyngeal reflux disease.
    Carroll TL; Werner A; Nahikian K; Dezube A; Roth DF
    Laryngoscope; 2017 Oct; 127 Suppl 6():S1-S13. PubMed ID: 28842999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. pH Impedance and high-resolution manometry in laryngopharyngeal reflux disease high-dose proton pump inhibitor failures.
    Carroll TL; Fedore LW; Aldahlawi MM
    Laryngoscope; 2012 Nov; 122(11):2473-81. PubMed ID: 22965767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnesium alginate versus proton pump inhibitors for the treatment of laryngopharyngeal reflux: a non-inferiority randomized controlled trial.
    Pizzorni N; Ambrogi F; Eplite A; Rama S; Robotti C; Lechien J; Schindler A
    Eur Arch Otorhinolaryngol; 2022 May; 279(5):2533-2542. PubMed ID: 35032204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with acid, high-fat and low-protein diet have higher laryngopharyngeal reflux episodes at the impedance-pH monitoring.
    Lechien JR; Bobin F; Muls V; Horoi M; Thill MP; Dequanter D; Rodriguez A; Saussez S
    Eur Arch Otorhinolaryngol; 2020 Feb; 277(2):511-520. PubMed ID: 31679054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nissen Fundoplication for Laryngopharyngeal Reflux After Patient Selection Using Dual pH, Full Column Impedance Testing: A Pilot Study.
    Carroll TL; Nahikian K; Asban A; Wiener D
    Ann Otol Rhinol Laryngol; 2016 Sep; 125(9):722-8. PubMed ID: 27217426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of gastroesophageal reflux disease on the clinical characteristics of patients with laryngopharyngeal reflux disease].
    Wang XY; Li JR; Zhang JH; Wang JS; Liu Z; Zhang C
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Oct; 57(10):1178-1184. PubMed ID: 36319122
    [No Abstract]   [Full Text] [Related]  

  • 15. Association between 24-hour combined multichannel intraluminal impedance-pH monitoring and symptoms or quality of life in patients with laryngopharyngeal reflux.
    Kim SI; Kwon OE; Na SY; Lee YC; Park JM; Eun YG
    Clin Otolaryngol; 2017 Jun; 42(3):584-591. PubMed ID: 28004504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eight weeks of omeprazole 20 mg significantly reduces both laryngopharyngeal reflux and comorbid chronic rhinosinusitis signs and symptoms: Randomised, double-blind, placebo-controlled trial.
    Anzić SA; Turkalj M; Župan A; Labor M; Plavec D; Baudoin T
    Clin Otolaryngol; 2018 Apr; 43(2):496-501. PubMed ID: 29024410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of nonacid reflux in laryngopharyngeal reflux diseases.
    Li J; Wang J; Wu M; Zhao J; Guo H
    Eur Arch Otorhinolaryngol; 2020 Oct; 277(10):2813-2819. PubMed ID: 32390084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between laryngopharyngeal reflux disease and gastroesophageal reflux disease based on synchronous esophageal and oropharyngeal Dx-pH monitoring.
    Wang L; Wang G; Li L; Fan X; Liu H; Sun Z; Han H; Li B; Ding R; Wu W
    Am J Otolaryngol; 2020; 41(3):102441. PubMed ID: 32144021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preliminary application of Dx-pH monitoring system in laryngopharyngeal reflux disease].
    Han HL; Zhao JH; Zhang YL; Wang M; Wang HF; Cheng JN; Feng Y; Luo KQ; Lyu QP
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Sep; 51(9):666-670. PubMed ID: 27666704
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative study on 24-hour multichannel intraluminal impedance-pH monitoring and Dx-pH monitoring in the diagnosis of laryngopharyngeal reflux].
    Wang JS; Li JR
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Apr; 53(4):270-275. PubMed ID: 29747251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.